LATEST NEWS

Trial in Progress: 2019-1001 A Phase I Study of NBTXR3 Activated by Radiotherapy for Locally Advanced or Borderline Resectable Pancreatic Ductal Adenocarcinoma (LAPC or BRPC)

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.